Unique ID issued by UMIN | UMIN000053880 |
---|---|
Receipt number | R000061503 |
Scientific Title | Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion. |
Date of disclosure of the study information | 2024/03/17 |
Last modified on | 2024/03/17 14:31:26 |
Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion.
Investigating the effects of continuous consumption of gummy candies containing reduced coenzyme Q10 on quality of life
Investigation of the effect of continuous consumption of gummy candies containing reduced coenzyme Q10 on oral-related quality of life with increased saliva secretion.
Investigating the effects of continuous consumption of gummy candies containing reduced coenzyme Q10 on quality of life
Japan |
healthy people
Dental medicine |
Others
NO
Evaluating whether continuous intake of gummies containing reduced coenzyme Q10 increases salivary secretion, thereby causing changes in oral health-related parameters
Efficacy
Exploratory
Stimulated saliva production and oral-related quality of life after 8 weeks of test food consumption.
Oral function test, saliva test, Assessment of eating discomfort and taste, Dietary Variety Score, Test food usage and health awareness survey
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Food |
Consume 2 gummy candies containing reduced coenzyme Q10 per day for 8 weeks
40 | years-old | <= |
Not applicable |
Male and Female
Persons with dry mouth sensation
Age 40 and over
Persons who are allergic to any of the components of the test food or reagent solution
Those who are taking more than 6 drugs.
Those who are taking drugs with an incidence of 5% or more of those listed as "xerostomia," "dry mouth," or "dysgeusia" in the adverse drug reactions in the package insert information of ethical drugs. If the frequency of occurrence is listed as "frequency unknown" in the accompanying information, the incidence is considered to be less than 5%.
Persons undergoing treatment for xerostomia
Persons with a history of epilepsy, Parkinson's disease, or Sjogren's syndrome, persons who have undergone or will undergo radiation therapy of the head and neck region, and persons who have undergone or will undergo anticancer drug therapy.
Persons who are unable to eat the test food
Person who smokes
Persons who are deemed ineligible by the dentist in charge of the examination
Persons who are deemed ineligible by the investigator.
20
1st name | MARIKO |
Middle name | |
Last name | MAEDA |
SUNSTAR INC.
Research and Development Division
566-0002
7F, KENTO Innovation Park NK Building, 3-17 Senrioka Shinmachi, Settsu, Osaka
090-8807-7530
mariko.maeda@jp.sunstar.com
1st name | KENTARO |
Middle name | |
Last name | IKEDA |
SUNSTAR INC.
Research and Development Division
566-0002
7F, KENTO Innovation Park NK Building, 3-17 Senrioka Shinmachi, Settsu, Osaka
090-8807-7530
kentaro.ikeda@jp.sunstar.com
SUNSTAR INC.
SUNSTAR INC.
Profit organization
Japan
SUNSTAR INC. Validity Assessment Committee
3-1 Asahimachi, Takatsuki-shi, Osaka, Japan
090-8807-7530
takeshi.kanamori@jp.sunstar.com
NO
サンスター株式会社 大阪サテライト研究所(大阪府)
2024 | Year | 03 | Month | 17 | Day |
Unpublished
29
Completed
2023 | Year | 07 | Month | 21 | Day |
2023 | Year | 07 | Month | 21 | Day |
2023 | Year | 08 | Month | 02 | Day |
2023 | Year | 11 | Month | 30 | Day |
2023 | Year | 12 | Month | 08 | Day |
2023 | Year | 12 | Month | 15 | Day |
2024 | Year | 03 | Month | 31 | Day |
2024 | Year | 03 | Month | 17 | Day |
2024 | Year | 03 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061503
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |